Completed PHASE4 INTERVENTIONAL 2-arm NCT02450383

Comparison of Two Different Surgical Approaches To Increase Peri-Implant Mucosa Thickness

Comparison of Two Different Surgical Approaches to Increase Peri-Implant Mucosa Thickness: A Randomized Controlled Clinical Trial

Sponsor: BioHorizons, Inc.

Conditions Peri-implant Mucosa Defect Tooth Loss

Interventions Acellular Dermal Matrix Autologous subepithelial connective tissue graft

Updated 8 times since 2017 Last updated: Sep 16, 2017 Started: Jan 31, 2015 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Peri-implant Mucosa Defect and Tooth Loss, this trial is completed. The trial is conducted by BioHorizons, Inc. and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Oct 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Oct 2017 [monthly]

Completed PHASE4

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioHorizons, Inc.
University of Iowa

Data source: University of Iowa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Iowa City, United States